Recombinant Human Thrombopoietin Market

Thrombopoietin (TPO), the major physiological regulator of platelet formation, binds to and activates TPO receptor on megakaryocytes, thereby promoting platelet production. Recombinant human thrombopoietin (rhTPO) is a novel therapeutic option for patients with immune thrombocytopenia (ITP) in China.

Recombinant Human Thrombopoietin Market contains market size and forecasts of Recombinant Human Thrombopoietin (rhTPO) in global, including the following market information:

Global Recombinant Human Thrombopoietin (rhTPO) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Human Thrombopoietin (rhTPO) Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Recombinant Human Thrombopoietin (rhTPO) companies in 2021 (%)

The global Recombinant Human Thrombopoietin (rhTPO) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

rhTPO Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Human Thrombopoietin (rhTPO) include Qilu Pharmaceutical, R&D Systems, Merck, Shionogi, MedChemExpress, PeproTech and Kelun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Recombinant Human Thrombopoietin (rhTPO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Human Thrombopoietin (rhTPO) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Recombinant Human Thrombopoietin (rhTPO) Market Segment Percentages, by Type, 2021 (%)

• rhTPO
• Fusion Protein

Global Recombinant Human Thrombopoietin (rhTPO) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Recombinant Human Thrombopoietin (rhTPO) Market Segment Percentages, by Application, 2021 (%)

• Medication
• Scientific Research

Global Recombinant Human Thrombopoietin (rhTPO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Recombinant Human Thrombopoietin (rhTPO) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Recombinant Human Thrombopoietin (rhTPO) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Recombinant Human Thrombopoietin (rhTPO) revenues share in global market, 2021 (%)
• Key companies Recombinant Human Thrombopoietin (rhTPO) sales in global market, 2017-2022 (Estimated), (KG)
• Key companies Recombinant Human Thrombopoietin (rhTPO) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Qilu Pharmaceutical
• R&D Systems
• Merck
• Shionogi
• MedChemExpress
• PeproTech
• Kelun